Nitric oxide and vascular reactivity in African American patients with hypertension.
Vita
Joseph A
JA
Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
D001741:Black or African American; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D001916:Brachial Artery / Q000503:physiopathology; D002227:Carbazoles / Q000627:therapeutic use; D002339:Carotid Arteries / Q000503:physiopathology; D000077261:Carvedilol; D003331:Coronary Vessels / Q000503:physiopathology; D004351:Drug Resistance; D004727:Endothelium / Q000378:metabolism*; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000208:ethnology* / Q000503:physiopathology*; D007249:Inflammation / Q000503:physiopathology; D007545:Isoproterenol / Q000494:pharmacology; D016210:Methacholine Chloride / Q000494:pharmacology; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000235:genetics; D052250:Nitric Oxide Synthase Type III; D005996:Nitroglycerin / Q000494:pharmacology; D009599:Nitroprusside / Q000494:pharmacology; D011412:Propanolamines / Q000627:therapeutic use; D016548:Prosencephalon / Q000098:blood supply; D044469:Racial Groups; D012039:Regional Blood Flow / Q000187:drug effects; D012307:Risk Factors; D014655:Vascular Resistance; D044465:White People
D000806:Angiotensin-Converting Enzyme Inhibitors; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D016210:Methacholine Chloride; D009599:Nitroprusside; D009569:Nitric Oxide; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D005952:Glucose-6-Phosphatase; D005996:Nitroglycerin; D007545:Isoproterenol